Latest News for: c5a receptor
Edit
Acute Respiratory Distress Syndrome Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ...
GetNews 12 Mar 2025
STSA 1002 is an investigative recombinant anti-human C5a IgG1 monoclonal antibody which acts by targeting complement C5a inhibitors C5a by specifically binding to anaphylatoxin C5a, C5a loses its ...
- 1